Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-26

FDA Approved: TWYNEO — Original Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved TWYNEO, a fixed-dose combination of tretinoin and benzoyl peroxide, for acne vulgaris under Galderma Laboratories, L.P.'s original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TWYNEO (Tretinoin and benzoyl peroxide)

Snippet

ORIG AP for TWYNEO (TRETINOIN AND BENZOYL PEROXIDE)